Understanding Growth Factors in Dentistry: Emdogain, PRF GEM21 and BMP2

LOD-348-00

Dr. Richard Miron

English

Understanding Growth Factors in Dentistry: Emdogain, PRF GEM21 and BMP2

Peri-implantitis: Etiology, Risk Factors, Treatment Options, Prevention

LOD-317-00

Prof. Eric Rompen

English

Peri-implantitis: Etiology, Risk Factors, Treatment Options, Prevention

The Story of Osseointegration - How Osseointegrated Oral Implants were Developed in Sweden by P-I Brånemark

LOD-307-00

Dr. Tomas Albrektsson

English

The Story of Osseointegration - How Osseointegrated Oral Implants were Developed in Sweden by P-I Brånemark

Case Acceptance - Making it Easy for Patients to Say Yes

LOD-272-00

Dr. Paul Homoly

This 30 minute video presentation by Dr. Paul Homoly will reveal some things that you can bring to your practice immediately to help your patients accept complete care.<br /><br />Dr. Homoly will tackle the term "chief complaint" (a term we dentists use all the time when consulting with our patients). He will explain why this term may not be working for you, and he will show you how you can replace this term with four other "chiefs": "Chief Condition", "Chief Disability", "Chief Benefit", and "Chief Fit Issue". He will explain each of these new terms and demonstrate how they can help your patients say "yes".

The Biodynamics of Osseointegration Facts and Clinical Implications

LOD-207-00

Dr. Peter Schupbach

Dental implants are placed into the alveolar bone, with the expectation that they become osseointegrated and that the periimplant mucosa will heal to the abutment surface and fulfill the primary functions of the periodontal tissues, which are attachment and protection of the soft tissue and the underlying bone.<BR><BR>This requires that the rather rigid ankylotic like connection between implant and bone replaces functionally the sophisticated suspension via the periodontal ligament as offered by the evolution and, that the structural framework of the periimplant mucosa matches the architecture of the gingiva. <BR><BR>The context of an understanding of the elicited host site interfacial healing response will be reiterated for the time period immediately following implant placement up to long term behavior. The role of the implants

Ridge Augmentation Using rhPDGF Growth Factors

LOD-121-00

Prof. Massimo Simion

This lecture covers the topic of ridge augmentation using the line of growthfactors termed rhPDGF (Gem-21) mixed with xenograft, TCP and autograft for implant placement. The scientific background and the first clinical cases are discussed and demonstrated. The new bone graft material shows to be an enhancement to the current technique of GBR.

Aspectos Biologicos em Implantes Unitarios (PORTUGUESE LANGUAGE ONLY)

LOD-073-00p

Dr. Mario Groisman

Aspectos Biologicos em Implantes Unitarios (PORTUGUESE LANGUAGE ONLY)

Clinical Pharmacology - What Every Dentist Should Know

LOD-072-00

Dr. Anthony Feck

Modern dentistry has expanded the arsenal of services to restore patients oral health and cosmetic needs like never before. These changes have corresponded to an increasingly complex medical environment where patients are presenting at a more advanced age, with more medical conditions, and taking more medications. Understanding the pharmacology as it relates to their systems and how the drugs they are taking, as well as those we intend to administer affect the patient, one another, and our planned treatment is necessary for a safe and successful outcome to our planned care.

Treating the Medically Complex Patient

LOD-069-00

Dr. Adi Garfunkel

&#8226 What is the dental-medical approach to the hypertensive patient?<br> &#8226 Could we treat patients with medication induced bleeding tendency?<br> &#8226 The use of adrenalin in local anesthesia constitutes at times a contradictory subject. How do we deal with this question?<br>

Bone Morphogenetic Proteins, A Realistic Alternative to Bone Grafting<br>

LOD-054-00

Dr. Ulf Wikesjo

Surgical placement of oral implants is governed by the prosthetic design and by the morphology and quality of the alveolar bone. Often, implant placement may be difficult, if at all possible, due to alveolar ridge aberrations. In consequence, prostheticly dictated implant positioning commonly entails bone augmentation procedures. One objective of our laboratory is to evaluate the biologic and clinical potential of bone morphogenetic proteins (BMPs) including rhBMP-2, rhOP-1/rhBMP-7, rhGDF-5, other candidate biologics, bone biomaterials, and devices for alveolar ridge augmentation and implant fixation. This presentation will discuss the unique biologic potential, the clinical relevance and perspectives of BMP technologies for alveolar bone augmentation and oral implant fixation, in particular the development of a unique bone-inductive oral implant. This presentation will also address merits and explain short-comings of current treatment protocol including bone biomaterials and guided bone regeneration (GBR). BMPs have an unparalleled potential to augment alveolar bone and support implant osseointegration and long-term functional loading. Inclusion of BMPs for alveolar augmentation and osseointegration will not only enhance predictability of existing clinical protocol but radically change current treatment paradigms. Inclusion of the bone-inductive oral implant in the treatment panorama may make 'grafting' and GBR procedures altogether obsolete.